Silencing of XB130 is associated with both the prognosis and chemosensitivity of gastric cancer.

Silencing of XB130 is associated with both the prognosis and chemosensitivity of gastric cancer.

XB130 is a newly characterized adaptor protein that was reported to promote thyroid tumor growth, but its role in the progression of other kinds of cancer such as gastric cancer (GC) remains unknown. Accordingly, we investigated the association between XB130 expression and the prognosis of GC patien...

Full description

Bibliographic Details
Main Authors: Min Shi, Weizhen Huang, Li Lin, Dayong Zheng, Qiang Zuo, Lin Wang, Nina Wang, Yajun Wu, Yulin Liao, Wangjun Liao
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22927913/?tool=EBI

Similar Items

Similar Items